celecoxib has been researched along with epidermal growth factor in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gately, S; Li, WW | 1 |
| Abramson, AL; Dannenberg, AJ; Shikowitz, MJ; Steinberg, BM; Wu, R | 1 |
| Chang, JK; Chou, CH; Ho, ML; Li, CJ; Wang, GJ | 1 |
| Bocca, C; Bozzo, F; Cannito, S; Miglietta, A; Parola, M | 1 |
| Benelli, R; Ferrari, N; Minghelli, S; Poggi, A; Tosetti, F; Venè, R | 1 |
| Barboro, P; Benelli, R; Brizzolara, A; Ferrari, N; Poggi, A; Tosetti, F; Venè, R | 1 |
| Astigiano, S; Barbieri, O; Barboro, P; Benelli, R; Capaia, M; Costa, D; Ferrari, N; Poggi, A | 1 |
1 review(s) available for celecoxib and epidermal growth factor
| Article | Year |
|---|---|
Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Celecoxib; Cell Movement; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Epidermal Growth Factor; Epoprostenol; Humans; Interleukin-12; Isoenzymes; Lactones; Matrix Metalloproteinases; Membrane Proteins; Neoplasms; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Signal Transduction; Sulfonamides; Sulfones; Thromboxane A2; Vascular Endothelial Growth Factor A | 2004 |
6 other study(ies) available for celecoxib and epidermal growth factor
| Article | Year |
|---|---|
Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
Topics: Apoptosis; Blotting, Western; Celecoxib; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Humans; Immunoenzyme Techniques; Laryngeal Neoplasms; Larynx; Membrane Proteins; Neoplasm Recurrence, Local; Papilloma; Papillomaviridae; Phosphatidylinositol 3-Kinases; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Respiratory Tract Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides | 2005 |
The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Topics: Anti-Inflammatory Agents; Celecoxib; Cell Proliferation; Cells, Cultured; Chromones; Cyclin-Dependent Kinase Inhibitor p27; Dextroamphetamine; Epidermal Growth Factor; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Indomethacin; Male; Morpholines; Osteoblasts; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Pyrazoles; Sulfonamides | 2010 |
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
Topics: beta Catenin; Cadherins; Celecoxib; Cell Hypoxia; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrazoles; Signal Transduction; Sulfonamides; Vimentin | 2012 |
Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.
Topics: Blotting, Western; Celecoxib; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Epidermal Growth Factor; ErbB Receptors; Fibroblasts; Flow Cytometry; Fluorescent Antibody Technique; Humans; Protein Transport; Real-Time Polymerase Chain Reaction; Signal Transduction | 2015 |
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
Topics: Amphiregulin; Androgen Antagonists; Antineoplastic Agents; Apoptosis; Celecoxib; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Male; Prostatic Neoplasms; Protein Kinase Inhibitors; Proteolysis; Receptor, ErbB-2; Receptor, ErbB-3; Receptors, Androgen; Ribonucleoproteins; Signal Transduction; Time Factors; Transcription, Genetic; Ubiquitin-Protein Ligases | 2017 |
Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer.
Topics: Amphiregulin; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cetuximab; Down-Regulation; Drug Resistance, Neoplasm; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Male; Mice, SCID; Neoplasm Invasiveness; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays | 2019 |